The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hall (2021)
Identifying risk profiles for marijuana vaping among U.S. young adults by recreational marijuana legalization status: a machine learning approach.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
han (2022)
Impact of the e-cigarette era on cigarette smoking among youth in the United States: a population-level study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
harrell (2022)
Risk factors for early use of e-cigarettes and alcohol: Dimensions and profiles of temperament.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hartmann (2023)
Characterizing Gas Exchange Physiology in healthy Young Electronic-Cigarette Users with hyperpolarized 129Xe MRI: a Pilot Study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
he (2021)
Effects of Electronic Nicotine Delivery Systems and Cigarettes on Systemic Circulation and Blood-Brain Barrier: Implications for Cognitive Decline.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
heldt (2021)
associations between eating disorder symptoms and smoking and vaping use and motives in college students.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
hennigan (2022)
E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
herman (2020)
Cigarette smoke and electronic cigarettes differentially activate bronchial epithelial cells.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
herr (2020)
Electronic nicotine delivery system use is related to higher odds of alcohol and marijuana use in adolescents: Meta-analytic evidence.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hershberger (2020)